Research location
Brighton
England, United Kingdom
Advertisement
Research activity in Brighton
England, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 20 trials and 24 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brighton
20 linked trials · page 1 of 1Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation
RECRUITING
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCNCT02438007 · 2015-06-01 · 1 site observation
TERMINATED
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerNCT02007512 · 2013-12-16 · 3 site observations
COMPLETED
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerNCT01889238 · 2013-06-12 · 3 site observations
COMPLETED
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung CancerNCT00433498 · 2007-01-01 · 1 site observation
COMPLETED
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By SurgeryNCT00403065 · 2006-10-01 · 1 site observation
COMPLETED
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerNCT00601406 · 2006-03-01 · 1 site observation
UNKNOWN
Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryNCT00301925 · 2005-12-16 · 1 site observation
UNKNOWN
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyNCT00268476 · 2005-07-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Radiation Therapy in Treating Women With Localized Breast CancerNCT00107497 · 2004-10-05 · 1 site observation
COMPLETED
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerNCT00078832 · 2003-09-01 · 1 site observation
COMPLETED
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone PainNCT00082927 · 2003-04-01 · 1 site observation
COMPLETED
Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerNCT00392535 · 2002-10-18 · 1 site observation
UNKNOWN
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast CancerNCT00030758 · 2001-10-01 · 1 site observation
UNKNOWN
Combination Chemotherapy in Treating Women With Resected Breast CancerNCT00033683 · 2001-02-01 · 1 site observation
UNKNOWN
Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerNCT00005588 · 1999-01-01 · 1 site observation
COMPLETED
Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerNCT00005587 · 1999-01-01 · 1 site observation
COMPLETED
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate CancerNCT00959023 · 1993-06-01 · 1 site observation
UNKNOWN
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung CancerNCT00003364 · 1993-01-01 · 1 site observation
COMPLETED
Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerNCT00002460 · 1987-09-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.